Skip to main content

ARCH Venture Partners — Portfolio, Page 8

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

236
Companies
$31.9B
Total invested
$143.1M
Avg. check
19
Industries
Biotechnology 22Health Care 13Therapeutics 10Life Science 8Medical 6Biopharma 4+13 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 169192 of 236
Areteia Therapeutics
February 2024

Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.

Biotechnology · Bernardsville$75.0M Series A
Basking Biosciences
January 2024

Basking Biosciences is to commercialize technology developed at Duke and Ohio State Universities.

Biotechnology · Durham$55.0M Series A
Accompany Health
January 2024

Accompany Health provides comprehensive in-home care to patients who live in sometimes underserved regions.

Health Care · Bethesda$56.0M Series A
Moonwalk Biosciences
January 2024

Moonwalk Biosciences operates a genomic medicine company that aims to provide a new class of precision epigenetic medications.

Artificial Intelligence (AI) · San Francisco$57.0M Series A
HI-Bio
January 2024

Human Immunology Biosciences is a biotechnology company that focuses on developing therapies for immune-mediated diseases.

Biotechnology · South San Francisco$95.0M Series B
Remix Therapeutics
January 2024

Remix Therapeutics is a biotechnology company that is working on developing small molecule medicines.

Biotechnology · Cambridge$60.0M Series Unknown
Tome Biosciences
December 2023

Tome Biosciences is a biotechnology company that develops programmable gene insertion technology.

Biotechnology · Watertown$213.0M Series A
Verve Therapeutics
November 2023

Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.

Biotechnology · Boston$143.8M Post Ipo Equity
UltraDx Bio
November 2023

UltraDx Bio is a biotechnology company that specializes in single-molecule digital high-sensitivity protein detection technology.

Biotechnology · Shanghai$13.7M Angel
Walden Biosciences
October 2023

Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease.

Biotechnology · CambridgeSeries B
Qihan Biotech
September 2023

Qihan Biotech is a gene-editing organ transplantation technology developer.

Biotechnology · Hangzhou$16.0M Series B
ROME Therapeutics
September 2023

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.

Biotechnology · Cambridge$72.0M Series B
Gossamer Bio
July 2023

Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

Biotechnology · San Diego$212.0M Post Ipo Equity
Bitterroot Bio
June 2023

Bitterroot Bio leverages the power of immunotherapy to develop and deliver novel medicines for cardiovascular disease.

Biotechnology · Palo Alto$145.0M Series A
Mozart Therapeutics
June 2023

Mozart is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases.

Biotechnology · Seattle$25.0M Series A
OncoResponse
May 2023

OncoResponse is an immuno-oncology biotech company developing cancer immunotherapies leveraging human immune system responses.

Biopharma · Seattle$14.0M Series D
CREATE Medicines
May 2023

CREATE Medicines is a clinical stage mRNA-immunotherapy company developing novel therapies for cancer and autoimmune diseases.

Biotechnology · Cambridge$73.0M Series A
Boundless Bio
May 2023

Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.

Biotechnology · La Jolla$100.0M Series C
Orbital Therapeutics
April 2023

Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.

Alternative Medicine · Cambridge$270.0M Series A
Recuro Health
April 2023

Recuro Health offers a holistic suite of virtual care services and supplemental benefits.

Health Care · Richardson$47.0M Series B
Paratus Sciences
February 2023

Paratus Sciences is dedicated to advancing human health and health security by comprehending the biology of bats.

Biotechnology · New York$100.0M Series A
Aera Therapeutics
February 2023

Aera Therapeutics is a biotechnology firm that employs its own protein nanoparticle (PNP) delivery platform.

Biopharma · Boston$193.0M Series B
Protillion Biosciences
December 2022

Protillion Biosciences specializes in the design and development of protein-based drugs.

Biopharma · Burlingame$18.0M Series A
Carrick Therapeutics
December 2022

Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.

Biotechnology · Dublin$60.0M Series C

Where ARCH Venture Partners invests

Biotechnology22
Health Care13
Therapeutics10
Life Science8
Medical6
Biopharma4

About ARCH Venture Partners's portfolio

How many companies has ARCH Venture Partners invested in?

ARCH Venture Partners has invested in 236 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does ARCH Venture Partners invest in?

ARCH Venture Partners's top investment sectors include Biotechnology, Health Care, Therapeutics, Life Science, Medical. The firm invests across 19 different industry categories.

What is ARCH Venture Partners's largest investment?

Among tracked funding rounds, Orbital Therapeutics received $270.0M in a Series A round. ARCH Venture Partners's total known invested capital is $31.9B.

What is the average investment size for ARCH Venture Partners?

ARCH Venture Partners's average investment size is $143.1M across its portfolio of 236 companies.

What are ARCH Venture Partners's most recent investments?

Recent ARCH Venture Partners portfolio additions include Areteia Therapeutics, Basking Biosciences, Accompany Health, Moonwalk Biosciences, HI-Bio. These companies were founded in 2020 or later.

Reach the founders behind these 236 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →